Playback speed
10 seconds
MD Anderson 2020 Updates on Biomarkers in Melanoma: Why Do We Need Liquid Biomarkers? Are CTSs/CMCs Prognostic? Can We Use Them to Guide Adjuvant Therapy Decisions?
89 views
December 1, 2020
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY